ResMed reported $668.74M in Loan Capital for its first fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Loan Capital Change
Ansell ANN:AU $ 541.8M 47.1M
Cochlear COH:AU $ 229.1M 3.3M
CSL CSL:AU $ 5.2B 136.2M
Estia Health EHE:AU $ 87.84M 87.21M
Fisher & Paykel Healthcare FPH:AU 87.3M 3.7M
Healius Ltd HLS:AU $ 1.27B 56.7M
Integral Diagnostics Ltd IDX:AU 330.58M 39.19M
Japara Healthcare JHC:AU 252.5M 22.36M
Mayne Pharma MYX:AU $ 332.7M 39.92M
Nanosonics Ltd NAN:AU $ 3.64M 2.62M
Opthea Ltd OPT:AU 0 0
Polynovo Ltd PNV:AU 7.12M 460.05K
Ramsay Health Care RHC:AU $ 8.43B 1.71B
Regis Healthcare REG:AU 94.57M 42.83M
ResMed RMD:AU $ 668.74M 756K
Sigma Healthcare Ltd SIG:AU 297.74M 122.14M
Sonic Healthcare SHL:AU $ 2.88B 197.28M
Telix Pharmaceuticals Ltd TLX:AU 1.91M 763K